Publications
Detailed Information
Salivary chemokine levels in patients with primary Sjogren`s syndrome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Yun Jong | - |
dc.contributor.author | Scofield, Robert H. | - |
dc.contributor.author | Hyon, Joon Young | - |
dc.contributor.author | Yun, Pil-Young | - |
dc.contributor.author | Lee, Eun Young | - |
dc.contributor.author | Song, Yeong Wook | - |
dc.contributor.author | Lee, Eun Bong | - |
dc.contributor.author | Lee, Hyo-Jung | - |
dc.date.accessioned | 2012-06-27T06:38:26Z | - |
dc.date.available | 2012-06-27T06:38:26Z | - |
dc.date.issued | 2010-09 | - |
dc.identifier.citation | RHEUMATOLOGY; Vol.49 9; 1747-1752 | ko_KR |
dc.identifier.issn | 1462-0324 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77606 | - |
dc.description.abstract | Methods. Unstimulated and stimulated whole saliva samples were obtained from pSS patients (n = 30) and age- and gender-matched patients with non-SS sicca (n = 30) and non-sicca healthy controls (n = 25). Salivary CCL2, CCL3, CCL4, CXCL8 and CXCL10 levels were measured using a Luminex bead-based multiplex assay. Results. Patients with pSS had significantly different distributions of salivary CCL3 (P = 0.0001 by the Kruskal-Wallis test), CCL4 (P < 0.00001), CXLC8 (P < 0.0001) and CXCL10 (P < 0.05) levels in unstimulated saliva and all chemokine levels in stimulated saliva when compared with non-SS sicca and non-sicca controls. In comparison with chemokine production rate, the CXCL8 and CXCL10 production rates were significantly higher in pSS than in non-SS sicca controls (P < 0.01 by the Mann-Whitney test). Logistic regression analyses revealed that salivary CXCL8 (P < 0.05) and CXCL10 (P < 0.05) were the significant discriminating chemokines between the pSS and non-SS sicca groups. Although CXCL8 and CXCL10 levels were not correlated with the focus scores, CXCL8 and CXCL10 levels were significantly associated with salivary gland dysfunction. Conclusion. These results support the notion that CXCL8 or CXCL10 chemokine plays a role in the pathogenesis of pSS. | ko_KR |
dc.description.sponsorship | This work was supported by the Seoul National
University Bundang Hospital, Korea (grant no. 03-05-004); and the National Institutes of Health (grant no. DE017561 to R.H.S.) | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | OXFORD UNIV PRESS | ko_KR |
dc.subject | Sjogren`s syndrome | ko_KR |
dc.subject | Sicca | ko_KR |
dc.subject | Saliva | ko_KR |
dc.subject | Chemokine | ko_KR |
dc.title | Salivary chemokine levels in patients with primary Sjogren`s syndrome | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이윤종 | - |
dc.contributor.AlternativeAuthor | 현준영 | - |
dc.contributor.AlternativeAuthor | 윤필영 | - |
dc.contributor.AlternativeAuthor | 이효정 | - |
dc.contributor.AlternativeAuthor | 이은영 | - |
dc.contributor.AlternativeAuthor | 이은봉 | - |
dc.contributor.AlternativeAuthor | 송영욱 | - |
dc.identifier.doi | 10.1093/rheumatology/keq121 | - |
dc.citation.journaltitle | RHEUMATOLOGY | - |
dc.description.citedreference | Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21 | - |
dc.description.citedreference | Sakai A, 2008, J IMMUNOL, V181, P2898 | - |
dc.description.citedreference | Milward MR, 2007, CLIN EXP IMMUNOL, V148, P307, DOI 10.1111/j.1365-2249.2007.03342.x | - |
dc.description.citedreference | ZYWALEWSKAGORNA N, 2007, KLIN OCZNA, V109, P435 | - |
dc.description.citedreference | Wakamatsu E, 2006, ARTHRITIS RHEUM, V54, P3476, DOI 10.1002/art.22176 | - |
dc.description.citedreference | Egerer T, 2006, ARTHRITIS RHEUM-US, V54, P1501, DOI 10.1002/art.21782 | - |
dc.description.citedreference | Sakai A, 2006, J PERIODONTOL, V77, P856, DOI 10.1902/iop.2006.050340 | - |
dc.description.citedreference | Hasegawa H, 2006, ARTHRITIS RHEUM, V54, P1174, DOI 10.1002/art.21745 | - |
dc.description.citedreference | Barone F, 2005, ARTHRITIS RHEUM, V52, P1773, DOI 10.1002/art.21062 | - |
dc.description.citedreference | Ogawa N, 2004, CLIN IMMUNOL, V112, P235, DOI 10.1016/j.clim.2004.03.008 | - |
dc.description.citedreference | Akpek EK, 2004, INVEST OPHTH VIS SCI, V45, P185, DOI 10.1167/iovs.03-0812 | - |
dc.description.citedreference | Wang PL, 2003, BIOCHEM BIOPH RES CO, V305, P970, DOI 10.1016/S0006-291X(03)00821-0 | - |
dc.description.citedreference | Jorkjend L, 2003, J ORAL REHABIL, V30, P369 | - |
dc.description.citedreference | Ogawa N, 2002, ARTHRITIS RHEUM, V46, P2730, DOI 10.1002/art.10577 | - |
dc.description.citedreference | Matin K, 2002, IMMUNOLOGY, V107, P222 | - |
dc.description.citedreference | Vitali C, 2002, ANN RHEUM DIS, V61, P554 | - |
dc.description.citedreference | Price EJ, 2002, RHEUMATOLOGY, V41, P416 | - |
dc.description.citedreference | Kuru B, 2002, J CLIN PERIODONTOL, V29, P92 | - |
dc.description.citedreference | Amin K, 2001, RESP MED, V95, P904, DOI 10.1053/rmed.2001.1174 | - |
dc.description.citedreference | Amft N, 2001, SCAND J IMMUNOL, V54, P62 | - |
dc.description.citedreference | Xanthou G, 2001, ARTHRITIS RHEUM, V44, P408 | - |
dc.description.citedreference | Tornwall J, 1999, LAB INVEST, V79, P1719 | - |
dc.description.citedreference | Pflugfelder SC, 1999, CURR EYE RES, V19, P201 | - |
dc.description.citedreference | Cuello C, 1998, BRIT J RHEUMATOL, V37, P779 | - |
dc.description.citedreference | Manthorpe R, 1997, J RHEUMATOL, V24, P8 | - |
dc.description.citedreference | *WHO, 1987, OR HLTH SURV BAS MET | - |
dc.description.tc | 3 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.